Insider Transactions in Q1 2022 at Frequency Therapeutics, Inc. (FREQ)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,326
-10.08%
|
$3,978
$3.53 P/Share
|
|
Feb 22
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,584
-6.5%
|
$4,752
$3.53 P/Share
|
|
Feb 22
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,069
-8.77%
|
$3,207
$3.53 P/Share
|
|
Feb 22
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,542
-14.73%
|
$4,626
$3.53 P/Share
|
|
Feb 22
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,069
-2.98%
|
$3,207
$3.53 P/Share
|
|
Feb 18
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,209
-8.42%
|
$3,627
$3.87 P/Share
|
|
Feb 18
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,411
-5.48%
|
$4,233
$3.87 P/Share
|
|
Feb 18
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
974
-7.4%
|
$2,922
$3.87 P/Share
|
|
Feb 18
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,404
-11.83%
|
$4,212
$3.88 P/Share
|
|
Feb 18
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
974
-2.64%
|
$2,922
$3.87 P/Share
|
|
Feb 17
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,118
-7.22%
|
$4,472
$4.19 P/Share
|
|
Feb 17
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,303
-4.81%
|
$5,212
$4.2 P/Share
|
|
Feb 17
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
901
-6.4%
|
$3,604
$4.19 P/Share
|
|
Feb 17
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
900
-2.38%
|
$3,600
$4.19 P/Share
|
|
Feb 17
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,296
-9.84%
|
$5,184
$4.2 P/Share
|
|
Feb 16
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,057
-6.39%
|
$4,228
$4.43 P/Share
|
|
Feb 16
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,233
-4.36%
|
$4,932
$4.43 P/Share
|
|
Feb 16
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
831
-5.58%
|
$3,324
$4.43 P/Share
|
|
Feb 16
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
851
-2.2%
|
$3,404
$4.43 P/Share
|
|
Feb 16
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,229
-8.54%
|
$4,916
$4.43 P/Share
|
|
Feb 15
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,168
-6.6%
|
$4,672
$4.33 P/Share
|
|
Feb 15
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,347
-8.56%
|
$5,388
$4.33 P/Share
|
|
Feb 15
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
863
-2.19%
|
$3,452
$4.33 P/Share
|
|
Feb 15
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,261
-4.27%
|
$5,044
$4.33 P/Share
|
|
Feb 15
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
844
-5.36%
|
$3,376
$4.33 P/Share
|
|
Feb 14
2022
|
Wendy S Arnold Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.87%
|
-
|
|
Feb 14
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.79%
|
-
|
|
Feb 14
2022
|
Christopher R. Loose Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+27.53%
|
-
|
|
Feb 14
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+37.18%
|
-
|
|
Feb 14
2022
|
Carl Le Bel Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.79%
|
-
|
|
Jan 18
2022
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
6,905
+1.45%
|
$0
$0.61 P/Share
|